Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Porter K, Walker AS; CASCADE Collaboration.

Lancet. 2003 Oct 18;362(9392):1267-74.

PMID:
14575971
2.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgren J, Hogg RS, de Wolf F, Fätkenheuer G, Staszewski S, d'Arminio Monforte A, Egger M; Antiretroviral Therapy (ART) Cohort Collaboration.

Lancet. 2006 Aug 5;368(9534):451-8. Review.

PMID:
16890831
3.

Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis.

Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E.

Public Health. 2016 Oct;139:3-12. doi: 10.1016/j.puhe.2016.05.004. Epub 2016 Jun 24. Review.

PMID:
27349729
4.

Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies.

Olsen CM, Knight LL, Green AC.

PLoS One. 2014 Apr 16;9(4):e95096. doi: 10.1371/journal.pone.0095096. eCollection 2014. Review.

6.

HIV disease and advanced age: an increasing therapeutic challenge.

Manfredi R.

Drugs Aging. 2002;19(9):647-69. Review.

PMID:
12381235
7.
8.

Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review.

Castilho JL, Melekhin VV, Sterling TR.

AIDS Res Hum Retroviruses. 2014 May;30(5):446-56. doi: 10.1089/AID.2013.0208. Epub 2014 Feb 7. Review.

9.

Effect of cigarette smoking on HIV acquisition, progression, and mortality.

Marshall MM, McCormack MC, Kirk GD.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):28-39. doi: 10.1521/aeap.2009.21.3_supp.28. Review.

10.

Safety and diagnostic value of brain biopsy in HIV patients: a case series and meta-analysis of 1209 patients.

Lee AM, Bai HX, Zou Y, Qiu D, Zhou J, Martinez-Lage Alvarez M, Zhang P, Tao Y, Tang X, Xiao B, Yang L.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):722-33. doi: 10.1136/jnnp-2015-312037. Epub 2016 Jan 12. Review.

PMID:
26758989
11.

Gender as a risk factor for survival among HIV patients on antiretroviral therapy: a systematic review protocol.

Asefa H, Dube L, Ewnetu H.

JBI Database System Rev Implement Rep. 2015 Sep 16;13(8):14-20. doi: 10.11124/jbisrir-2015-2086. Review. No abstract available.

PMID:
26455931
12.

Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review.

Milloy MJ, Marshall BD, Kerr T, Buxton J, Rhodes T, Montaner J, Wood E.

AIDS. 2012 Jun 1;26(9):1049-63. doi: 10.1097/QAD.0b013e32835221cc. Review.

13.

Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy.

Moore RD.

Semin Hematol. 2000 Oct;37(4 Suppl 6):18-23. Review.

PMID:
11068952
14.

Acute coronary syndromes in patients with HIV.

Seecheran VK, Giddings SL, Seecheran NA.

Coron Artery Dis. 2017 Mar;28(2):166-172. doi: 10.1097/MCA.0000000000000450. Review.

15.

A balance of risks for the treatment of the chronically HIV-infected asymptomatic individual.

Watson C, Fisher M.

Clin Med (Lond). 2003 May-Jun;3(3):212-6. Review. No abstract available.

PMID:
12848253
16.

HIV infection in the elderly.

Nguyen N, Holodniy M.

Clin Interv Aging. 2008;3(3):453-72. Review.

17.

Management of prostate cancer in HIV-positive patients.

Wosnitzer MS, Lowe FC.

Nat Rev Urol. 2010 Jun;7(6):348-57. doi: 10.1038/nrurol.2010.61. Epub 2010 Apr 27. Review.

PMID:
20421876
18.

Survival analysis in infectious disease research: describing events in time.

Cole SR, Hudgens MG.

AIDS. 2010 Oct 23;24(16):2423-31. doi: 10.1097/QAD.0b013e32833dd0ec. Review.

Supplemental Content

Support Center